PRL and breast cancer: More cases (n = 300, 18.3%) had been exposed to prolactin-increasing antipsychotics for 1–<5 years than controls (n = 1384, 16.9%); compared with minimal exposure (< 1 year), the aOR for breast cancer was 1.20 (95% CI = 1.03–1.41).